A Potential Antitumor Effect of Dendritic Cells Fused with Cancer Stem Cells in Hepatocellular Carcinoma
HCC stem cells were reported as posttreatment residual tumor cells that play a pivotal role in tumor relapse. Fusing dendritic cells (DCs) with tumor cells represents an ideal approach to effectively activate the antitumor immunity in vivo. DC/HCC stem cell vaccine provides a potential strategy to g...
Saved in:
Main Authors: | Ye-Bin Pang (Author), Jian He (Author), Bi-Yu Cui (Author), Sheng Xu (Author), Xi-Lei Li (Author), Man-Ya Wu (Author), Rong Liang (Author), Yan Feng (Author), Xing Guo (Author), Xue-Hui Zhang (Author), Xiao-Ling Luo (Author) |
---|---|
Format: | Book |
Published: |
Hindawi Limited,
2019-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Dendritic Cells and Immunogenic Cancer Cell Death: A Combination for Improving Antitumor Immunity
by: María Julia Lamberti, et al.
Published: (2020) -
The Antitumor Didox Acts as an Iron Chelator in Hepatocellular Carcinoma Cells
by: Michela Asperti, et al.
Published: (2019) -
Exposure to Low-Dose Radiation Enhanced the Antitumor Effect of a Dendritic Cell Vaccine
by: Sinian Wang, et al.
Published: (2019) -
Induction of ROS and DNA damage-dependent senescence by icaritin contributes to its antitumor activity in hepatocellular carcinoma cells
by: Shikang Wang, et al.
Published: (2019) -
Pleurotus ferulae polysaccharides improve the antitumor efficacy of therapeutic human papillomavirus dendritic cell-based vaccine
by: Jinyu Li, et al.
Published: (2019)